The complexity of synthetic peptide products is increasing, whether as reagents used in research or as therapeutic active pharmaceutical ingredients (API).

As researchers understand more about the biochemical systems and invent ever more sophisticated products, manufacturing methods must keep pace.

This white paper looks at a number of challenging product classes, the specific problems they present and potential solutions, including long peptides, multi-peptide cocktails and site-specifically modified products.

Download this white paper to find out more.